Skip to content
Recall Observatory FDA recall evidence

Device product

The Access Cortisol assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of cortisol levels in human serum, plasma (heparin, EDTA) and urine using the Access Immunoassay Systems.

Z-0313-2025

September 30, 2024

Class II

Product summary

Firm
Beckman Coulter, Inc.
Event
Event 95473
Status
Ongoing
Classification
Class II
Quantity
149 units
Official record key
device-enforcement:Z-0313-2025

Official wording

Reason: The Access Cortisol assay protocol file (APF) applies an incorrect calibration curve acceptance parameter at the S1 calibrator level that can lead to a high rate of calibration failures which can vary by reagent lot number. Calibration failure would lead to delay of measurement results reporting and potential injuries.

Code information: UDI/DI 15099590231118, all lots

Distribution pattern: Worldwide distribution.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    The Access Cortisol assay protocol file (APF) applies an incorrect calibration curve acceptance parameter at the S1 calibrator level that can lead to a high rate of calibration failures which can vary by reagent lot number. Calibration failure would lead to delay of measurement results reporting and potential injuries.